Michael J. Pellini

This profile gathers the share dealings of Michael J. Pellini across 3 companies, led by Adaptive Biotechnologies Corp, Singular Genomics Systems, Inc. and GeneDx Holdings Corp. Over a trading history stretching from 20 May 2021 to 4 March 2025, the count stands at 10 filings.

On the market, this insider has only ever bought: 1 purchase, €85k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants and 3 option exercises.

On 6 March 2025 came the latest disclosure, a share grant in Adaptive Biotechnologies Corp. The most recent open-market purchase was published on 19 May 2022, 1,613 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.